← Leaderboards
Kotaro Nakanishi
Ohio State University
$5,615,568
Attributed
$5,615,568
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2017–25$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,615,568 · 3
By mechanism
R01$5,190,771 · 2
R21$424,797 · 1
Top collaborators
No co-investigators on record.
Most similar at Ohio State University
Same institution · by research overlap
- Nicholas C Denko$10,501,039
- Zihai Li$25,199,729
- Steffen Lindert$2,554,678
- Daniel W Binzel$853,019
- Yasuko Rikihisa$20,217,328
Others in their field
Other Emerging Leaders on “Proteins”
- John Damon Chodera · Sloan-Kettering Inst Can Research$50,971,767
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Susan M Landau · University Of California Berkeley$47,252,026
- Timothy Fouts · Advanced Bioscience Laboratories, Inc.$40,723,314
- Chris Karlovich · Leidos Biomedical Research, Inc.$38,534,220
- Mathangi Thiagarajan · Leidos Biomedical Research, Inc.$37,695,154
Research focus
ProteinsMutantRna-Induced Silencing ComplexMicrornasStructureRna InterferenceComplexGuide RnaMolecularBindingGene ExpressionTranscriptome SequencingMessenger RnaNucleotidesCellsBaseOutcome StudyGene SilencingBinding SitesInsightTranslational RepressionSiteBinding ProteinsInternal Ribosome Entry Site
Grant awards (20)
Structural and molecular basis for cityRNA (cleavage-inducing tiny RNA)-directed RNA cleavage by AGO3$324,450
R01 · FY2025 · GM · contact PI
Target specificity of human RNA-induced silencing complex$316,592
R01 · FY2025 · GM · contact PI
Structural and molecular basis for cityRNA (cleavage-inducing tiny RNA)-directed RNA cleavage by AGO3$398,407
R01 · FY2024 · GM · contact PI
Target specificity of human RNA-induced silencing complex$316,592
R01 · FY2024 · GM · contact PI
Tiny RNAs as new potential biomarkers for gammaherpesvirus-driven neurological and central nervous system diseases$192,590
R21 · FY2024 · AI · contact PI
Target specificity of human RNA-induced silencing complex$145,300
R01 · FY2024 · GM · contact PI
Target specificity of human RNA-induced silencing complex$316,592
R01 · FY2023 · GM · contact PI
Structural and molecular basis for cityRNA(cleavage-inducing tiny RNA)-directed RNA cleavage by AGO3$298,641
R01 · FY2023 · GM · contact PI
Tiny RNAs as new potential biomarkers for gammaherpesvirus-driven neurological and central nervous system diseases$232,207
R21 · FY2023 · AI · contact PI
Target specificity of human RNA-induced silencing complex$146,704
R01 · FY2023 · GM · contact PI
Target specificity of human RNA-induced silencing complex$335,592
R01 · FY2022 · GM · contact PI
Structural and molecular basis for cityRNA(cleavage-inducing tiny RNA)-directed RNA cleavage by AGO3$298,641
R01 · FY2022 · GM · contact PI
Structural and molecular basis for cityRNA (cleavage-inducing tiny RNA)-directed RNA cleavage by AGO3$199,982
R01 · FY2022 · GM · contact PI
Target specificity of human RNA-induced silencing complex$298,713
R01 · FY2021 · GM · contact PI
Structural and molecular basis for cityRNA(cleavage-inducing tiny RNA)-directed RNA cleavage by AGO3$298,641
R01 · FY2021 · GM · contact PI
Target specificity of human RNA-induced silencing complex$299,134
R01 · FY2020 · GM · contact PI
Structural and molecular basis for cityRNA(cleavage-inducing tiny RNA)-directed RNA cleavage by AGO3$298,641
R01 · FY2020 · GM · contact PI
Target specificity of human RNA-induced silencing complex$299,531
R01 · FY2019 · GM · contact PI
Target specificity of human RNA-induced silencing complex$299,906
R01 · FY2018 · GM · contact PI
Target specificity of human RNA-induced silencing complex$298,712
R01 · FY2017 · GM · contact PI